Contralateral catheterization of the ophthalmic artery to deliver intra-arterial chemotherapy in retinoblastoma

Neuroradiol J. 2021 Aug;34(4):370-372. doi: 10.1177/19714009211024632. Epub 2021 Jun 13.

Abstract

Retinoblastoma is the most frequent ocular malignancy in the pediatric population and intra-arterial chemotherapy has emerged as the first-line treatment of this entity with cure rates ranging from 33-100%, depending on the severity of the disease. We present the case of an advanced retinoblastoma in a pediatric patient who underwent intra-arterial chemotherapy through a contralateral route due to unsuccessful catheterization of the ophthalmic artery. The patient was diagnosed with a class D retinoblastoma which underwent the catheterization of the ophthalmic artery through the contralateral internal carotid and through the anterior communicating artery. In this case, intra-arterial chemotherapy administration was successfully delivered without complications. Contralateral routes for intra-arterial chemotherapy are safe and allow adequate penetration of the chemotherapeutic drugs in cases where a well-developed anterior communicating artery is present.

Keywords: Retinoblastoma; chemosurgery; intra-arterial chemotherapy; ophthalmic artery.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Catheterization
  • Child
  • Humans
  • Infant
  • Ophthalmic Artery / diagnostic imaging
  • Retinal Neoplasms* / diagnostic imaging
  • Retinal Neoplasms* / drug therapy
  • Retinoblastoma* / diagnostic imaging
  • Retinoblastoma* / drug therapy
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antineoplastic Agents